等待开盘 11-09 09:30:00 美东时间
+0.130
+4.45%
今日重点评级关注:瑞银:维持Liberty Media"中性"评级,目标价从110美元升至1116美元;杰富瑞:维持伊诺维奥制药"买入"评级,目标价从3美元升至8美元
今天 14:00
Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $90 to $55.
11-07 00:04
Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(1.76) per share which missed the analyst consensus estimate of $(1.59) by 10.69 percent. This is a 62.07 percent increase over losses of $(4.64) per share from the same period last year.
11-06 05:41
11月3日,艾切托(ACET)收跌6.43%,报3.2美元,成交额83.36万美元,市值2995.65万美元。 行情数据 • 开盘价:3.42美元 • 最高价...
11-03 08:36
10月24日,艾切托(ACET)收跌6.78%,报3.99美元,成交额66.55万美元,市值3735.22万美元。 行情数据 • 开盘价:4.22美元 • 最高...
10-24 07:35
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:33
今日重点评级关注:HC Wainwright & Co.:维持NeuroSense Therapeutics"买入"评级,目标价从8美元升至52美元;HC Wainwright & Co.:维持艾切托"买入"评级,目标价从27美元升至34美元
09-29 08:33
Adicet Bio, Inc. (NASDAQ:ACET), a clinical-stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that the Company will report clinical data from the Phas...
09-26 04:01
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25